Rho-Kinase Inhibitors for the Treatment of Refractory Diabetic Macular Oedema

Diabetic macular oedema (DMO) is one of the leading causes of vision loss associated with diabetic retinopathy (DR). New insights in managing this condition have changed the paradigm in its treatment, with intravitreal injections of antivascular endothelial growth factor (anti-VEGF) having become th...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Milagros Mateos-Olivares, Luis García-Onrubia, Fco. Javier Valentín-Bravo, Rogelio González-Sarmiento, Maribel Lopez-Galvez, J. Carlos Pastor, Ricardo Usategui-Martín, Salvador Pastor-Idoate
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2021-07-01
Serija:	Cells
Teme:	diabetic macular oedema diabetic retinopathy macular oedema rho-associated kinases
Online dostop:	https://www.mdpi.com/2073-4409/10/7/1683
Oznake:	Označite Brez oznak, prvi označite!